Announcing: Our Challenge Festival Grand Champion, HandUp
After seven months of searching, we’re so excited to announce the first ever Challenge Festival grand champion.
Of the 64 startups that competed throughout the week and the 8 finalists that pitched this evening at the Global Finals, our judges selected HandUp as the overall winner.
According to HandUp Cofounder Rose Broome, her company addresses two major social problems: poverty and homelessness. Through its pilot program in San Francsico, HandUp is allowing local users to donate money to specific men and women in need. HandUp’s model also ensures that 100 percent of the funds go toward basics like food, housing and medical care
HandUp walks away with a $150,000 investment, as well as the full support of 1776 and partners.
In addition to the overall winner, we’re also happy to announce our category winners, each of whom are eligible to receive a $100,000 investment. The winners are:
Education: EduCanon —EduCanon is an online learning environment to build and share interactive video lessons. Teachers begin with any YouTube video content (screencasts, Khan Academy, Minute Physics, TED, NOVA, etc.) and transform what is traditionally passive content into an active experience for students through time-embedded formative assessments. The EduCanon platform incorporates teaching pedagogy and the best practices of online video environments.
Energy: PlugSurfing — PlugSurfing is the pioneering app empowering electric vehicle drivers to find and pay for charging throughout Europe. PlugSurfing solves the problem EV drivers face of closed networks: now instead of the 100 RFID cards needed to charge everywhere, a driver can use the one thing he is never without: a smartphone.
Health: CancerIQ — CancerIQ offers a web-based service that gives oncologists at hospitals everywhere access to a large, curated repository of similar patients, guidelines, and network of providers at top institutions. The core technology, which team members spent seven years developing, also uses algorithms to interpret molecular diagnostic data, identify high risk patients, and lead oncologists toward actionable interventions.